Welcome to our dedicated page for abrdn World Healthcare news (Ticker: THW), a resource for investors and traders seeking the latest updates and insights on abrdn World Healthcare stock.
abrdn World Healthcare Fund (THW) provides investors with focused exposure to global healthcare markets through strategic investments in pharmaceuticals, biotechnology, and medical technology. This news hub offers essential updates on the fund's portfolio activity, distribution policies, and market positioning.
Access real-time announcements including earnings reports, strategic acquisitions, and regulatory developments. Our curated collection ensures you stay informed about capital allocation decisions, sector-specific trends, and management commentary relevant to this closed-end healthcare fund.
Key updates cover portfolio rebalancing across therapeutic areas, income distribution details, and analysis of healthcare market dynamics. Bookmark this page for centralized access to THW's operational developments and industry insights that matter to long-term investors.
Tekla World Healthcare Fund (NYSE: THW) has completed its one-for-three non-transferable rights offering, which expired on April 6, 2021. Shareholders could purchase one newly issued share for every three rights held at a subscription price of $14.262 per share, equating to 95% of the volume weighted average price on the NYSE. The offering attracted total subscriptions of approximately $100.4 million, including oversubscriptions. Shares are expected to be issued around April 9, 2021.
Tekla World Healthcare Fund has renewed its share repurchase program, allowing the purchase of up to 12% of outstanding common shares until July 14, 2022. This initiative aims to enhance shareholder value and reduce the market price discount relative to the net asset value per share. The timing and amount of repurchases will be at the discretion of Tekla Capital Management. However, there is no guarantee that share repurchases will increase market prices or net asset value.
On March 9, 2021, Tekla World Healthcare Fund announced a monthly cash distribution of $0.1167 per share, with a record date of March 19, 2021. The payment will be made on March 31, 2021, and the fund will trade ex-distribution on March 18, 2021. Only participants in the Fund's Dividend Reinvestment and Stock Purchase Plan will have distributions automatically reinvested in shares. The fund specializes in investments within the healthcare sector and is advised by Tekla Capital Management.
Tekla World Healthcare Fund announced a non-transferable rights offering that allows shareholders to subscribe for additional shares. Shareholders of record as of March 8, 2021, will receive rights to acquire one share for every three rights held. The rights can be exercised from March 16 to April 6, 2021. The subscription price will be based on a formula related to the volume-weighted average price of shares on the NYSE. This offering aims to increase the Fund's assets, potentially lowering fixed expenses as a percentage of net assets.
On February 9, 2021, Tekla World Healthcare Fund announced a monthly cash distribution of $0.1167 per share. The record date for this distribution is February 19, 2021, with payment scheduled for February 26, 2021. The Fund's shares will trade ex-distribution on February 18, 2021. Only participants in the Fund's Dividend Reinvestment and Stock Purchase Plan will have their distributions automatically reinvested in Fund shares. Tekla World Healthcare Fund (NYSE: THW) focuses on healthcare investments and is managed by Tekla Capital Management LLC.
On January 11, 2021, Tekla World Healthcare Fund announced a monthly cash distribution of $0.1167 per share. The record date is January 21, 2021, with payment scheduled for January 29, 2021. The Fund will trade ex-distribution on January 20, 2021. Only participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan (DRIP) will see automatic reinvestment of distributions. Tekla World Healthcare Fund, listed under the ticker THW, focuses on investments in the healthcare sector and is managed by Tekla Capital Management LLC.
On January 7, 2021, Tekla World Healthcare Fund's Board of Trustees authorized a preliminary registration statement for a proposed rights offering to shareholders. The offering aims to acquire additional shares, with key details yet to be established. Proceeds from the offering would enable the Fund to seize new investment opportunities while maintaining existing holdings. Shareholders will receive non-transferable rights to acquire additional shares, with the subscription price expected below the market price at that time. The offering period and record date will be announced later.
On December 8, 2020, Tekla World Healthcare Fund declared a monthly cash distribution of $0.1167 per share, with a record date of December 18, 2020, and a payable date of December 31, 2020. The Fund will trade ex-distribution on December 17, 2020. Cash distributions will be automatically reinvested in shares for participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan. As a closed-end fund, Tekla World Healthcare Fund, trading under NYSE: THW, focuses on investment in healthcare companies and is advised by Tekla Capital Management LLC.
On November 30, 2020, Tekla World Healthcare Fund (THW) distributed $0.1167 per share. This distribution primarily stems from return of capital rather than net investment income or realized capital gains. The fund reported net unrealized appreciation of portfolio securities at approximately $22 million, despite cumulative total returns at NAV showing a -5.47% decline for the fiscal year. The annualized current distribution rate is 10.57% as of October 31, 2020. Distributions may vary monthly based on realized gains and losses, and actual amounts for tax purposes will be finalized at the fiscal year's end.
On November 9, 2020, Tekla World Healthcare Fund announced a monthly cash distribution of $0.1167 per share, with the record date set for November 20, 2020 and a payable date of November 30, 2020. The Fund's shares will trade ex-distribution on November 19, 2020. This closed-end fund focuses on investments within the healthcare sector and is managed by Tekla Capital Management LLC. It is important to note that only participants in the Fund’s Dividend Reinvestment and Stock Purchase Plan will have their cash distributions automatically reinvested.
